A COMPARISON OF THE PLASMINOGEN-ACTIVATOR ACTIVITY UNITS OF URINARY-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)

被引:0
|
作者
CREIGHTONKEMPSFORD, LJ [1 ]
PRING, JB [1 ]
GAFFNEY, PJ [1 ]
机构
[1] NATL INST BIOL STAND & CONTROLS,DIV HAEMATOL,BLANCHE LANE,POTTERS BAR EN6 3QG,HERTS,ENGLAND
关键词
STANDARDS; TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA); URINARY-TYPE PLASMINOGEN ACTIVATORS (U-PA); FIBRINOLYSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The earliest tissue plasminogen activator (t-PA) preparations prepared from melanoma cells were expressed in urinary-type plasminogen activator (u-PA) units of activity using the u-PA International Standard (66/46). This report describes a comparison between u-PA and t-PA units by various types of fibrin plate procedure using both human and bovine fibrin. Within the biometric limits of this procedure it was found that the potency ratio of u-PA/t-PA was 3.5 (human fibrin), 5.29 (enriched bovine fibrin) and 4.6 (crude bovine fibrin). Specific activity figures of approximately 100 000 IU/mg for pure t-PA using the urokinase standard (66/46) would convert to approximately 350 000-530 000 IU/mg using the International Standards for t-PA (83/517 and 87/670). This latter figure is compatible with the reported specific activity for purified preparations of recombinant t-PA.
引用
收藏
页码:481 / 483
页数:3
相关论文
共 50 条
  • [31] FIBRIN-SPECIFIC THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA)
    COLLEN, D
    ATHEROSCLEROSIS, 1988, 70 (1-2) : 188 - 189
  • [32] THE 5'-REGION OF THE HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) GENE
    FISHER, R
    SCHLEUNING, WD
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 4 - 4
  • [33] PREVENTION OF POSTOPERATIVE ADHESIONS BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN THE RABBIT
    DORR, PJ
    VEMER, HM
    BROMMER, EJP
    WILLEMSEN, WNP
    VELDHUIZEN, RW
    ROLLAND, R
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1990, 37 (03): : 287 - 291
  • [34] EFFECT OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) ON BACTERIAL-ENDOCARDITIS
    BUITING, AGM
    THOMPSON, J
    EMEIS, JJ
    MATTIE, H
    BROMMER, EJP
    VANFURTH, R
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 258 - 258
  • [35] CORONARY THROMBOLYSIS WITH A MUTANT OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)
    JANG, IK
    CAMBIER, P
    VANDEWERF, F
    LARSEN, GR
    COLLEN, D
    CIRCULATION, 1987, 76 (04) : 376 - 376
  • [36] REGULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) GENE-EXPRESSION
    MEDCALF, RL
    RUEGG, M
    SCHLEUNING, WD
    COUSIN, E
    KRUITHOF, EKO
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 867 - 867
  • [37] URINARY TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN RENAL-TRANSPLANT PATIENTS
    IKEGAMI, M
    ISHII, T
    UEMURA, T
    KUNIKATA, S
    MATSUURA, T
    AKIYAMA, T
    KURITA, T
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (04) : 1547 - 1548
  • [38] AN ELECTROCHEMICAL ASSAY FOR TISSUE PLASMINOGEN-ACTIVATOR (T-PA)
    CARDOSI, M
    HO, WO
    ATHEY, D
    MCNEIL, C
    ELECTROANALYSIS, 1992, 4 (03) : 285 - 290
  • [39] TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AFTER KIDNEY-TRANSPLANTATION
    VOLK, C
    LORETH, RM
    ALBERT, FW
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1335 - 1335
  • [40] EFFECT OF ISOTRETINOIN ON ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN HUMANS
    WALLNOFER, AE
    VANGRIENSVEN, JMT
    SCHOEMAKER, HC
    COHEN, AF
    LAMBERT, W
    KLUFT, C
    MEIJER, P
    KOOISTRA, T
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (06) : 1005 - 1008